Research Article
Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal
Table 2
Categorical demographic characteristics and indicators of HCV management, treatment, and outcomes according to Aboriginal status.
| Categorical variables | Aboriginal status | value | Aboriginal () | Non-Aboriginal () |
| Underwent biopsy | 44.4 | 48.9 | 0.517 | Underwent Fibroscan | 13.0 | 15.3 | 0.64 | Initiated HCV antiviral therapy | 37.0 | 40.8 | 0.574 | Use of erythropoietin | 0.0 | 6.4 | 0.054 | Treatment type | | | 0.262 | Naive | 63.0 | 60.7 | | Interferon based | 37.0 | 34.5 | | DAA IFN | 0.0 | 4.7 | | Treatment status | | | 0.001 | Treatment failure | 10.0 | 13.3 | | Side effects/adverse event | 25.0 | 21.3 | | Adherence/substance abuse/lack of follow-up | 25.0 | 4.6 | | Completed treatment | 40.0 | 60.9 | |
| Achieved SVR | 56.3 | 58.9 | 0.833 | Achieved SVR by genotype | | | | G1 | 60.0 | 54.3 | 0.720 | G2 | 0.0 | 82.6 | 0.035 | G3 | 75.0 | 66.4 | 0.720 | G4 | — | 32.4 | — | G5 | — | 100.0 | — | G6 | — | 77.8 | — |
|
|
The results represent “%”.
|